Nidan Laboratories & Healthcare Ltd

AI
Nidan Laborator. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Nidan Laboratories & Healthcare Ltd

₹ 12.6 -1.94%
21 Oct - close price
nidanhealthcare.co.in NSE - SME: NIDAN
About

Incorporated in 2000, Nidan Laboratories & Healthcare Ltd is in the business of providing various Healthcare and Diagnostics Services[1]

Key Points

Business Overview:[1]
NLHL is a Healthcare Division of Nidan Group. It operates 35 diagnostic centers across Greater Mumbai under the Nidan Diagnostics brand. Services include CT scan, MRI, Ultrasound, 2D Echo, ECG, and more.

Website NSE - SM
  • Market Cap ₹ 17.6 Cr.
  • Current Price ₹ 12.6
  • High / Low ₹ 24.9 / 11.5
  • Stock P/E 9.88
  • Book Value ₹ 50.1
  • Dividend Yield 0.00 %
  • ROCE 5.99 %
  • ROE 2.58 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.25 times its book value
  • Company's working capital requirements have reduced from 87.8 days to 33.6 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 4.62% over past five years.
  • Company has a low return on equity of 1.81% over last 3 years.
  • Promoter holding has decreased over last 3 years: -5.75%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
13.14 14.09 10.18 11.82 12.35 10.53 13.99 13.12 12.42
9.52 8.93 8.54 8.48 9.24 7.93 11.53 10.58 10.12
Operating Profit 3.62 5.16 1.64 3.34 3.11 2.60 2.46 2.54 2.30
OPM % 27.55% 36.62% 16.11% 28.26% 25.18% 24.69% 17.58% 19.36% 18.52%
0.39 0.33 3.00 1.52 -5.29 1.03 1.22 1.17 0.29
Interest 0.95 1.03 1.19 0.98 1.20 0.88 1.26 0.88 1.07
Depreciation 0.87 1.44 1.66 1.28 1.59 1.34 1.07 0.92 0.98
Profit before tax 2.19 3.02 1.79 2.60 -4.97 1.41 1.35 1.91 0.54
Tax % 61.19% 23.51% 31.28% 26.15% 3.62% 21.99% 34.81% 24.61% 87.04%
0.86 2.32 1.22 1.92 -5.15 1.10 0.88 1.43 0.07
EPS in Rs 0.62 1.67 0.88 1.38 -3.71 0.79 0.63 1.03 0.05
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
20.07 21.41 20.38 29.66 24.27 24.18 24.53 25.54
12.23 13.78 11.49 20.25 17.47 17.74 19.47 20.70
Operating Profit 7.84 7.63 8.89 9.41 6.80 6.44 5.06 4.84
OPM % 39.06% 35.64% 43.62% 31.73% 28.02% 26.63% 20.63% 18.95%
0.37 0.01 1.06 0.40 3.33 -3.76 2.25 1.46
Interest 4.75 3.74 3.46 2.66 2.22 2.18 2.14 1.96
Depreciation 3.24 3.19 3.18 2.63 3.10 2.87 2.41 1.90
Profit before tax 0.22 0.71 3.31 4.52 4.81 -2.37 2.76 2.44
Tax % 0.00% 0.00% 30.21% 41.15% 26.40% 36.29% 28.26% 38.11%
0.22 0.71 2.30 2.66 3.54 -3.23 1.98 1.51
EPS in Rs 0.22 0.72 2.32 1.91 2.55 -2.32 1.42 1.09
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 5%
3 Years: 2%
TTM: 4%
Compounded Profit Growth
10 Years: %
5 Years: -5%
3 Years: -19%
TTM: -8%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -25%
1 Year: -32%
Return on Equity
10 Years: %
5 Years: 3%
3 Years: 2%
Last Year: 3%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 9.90 9.90 9.90 13.90 13.90 13.90 13.90 13.90
Reserves 0.41 1.13 3.43 52.00 55.54 52.31 54.28 55.79
32.16 34.35 38.04 19.29 10.93 12.44 11.11 11.17
0.58 -0.17 2.37 3.29 4.03 3.90 3.65 3.14
Total Liabilities 43.05 45.21 53.74 88.48 84.40 82.55 82.94 84.00
23.28 20.10 19.92 20.46 21.39 17.95 16.33 14.91
CWIP 0.00 0.00 0.23 3.81 0.00 0.04 0.15 0.15
Investments 0.53 0.53 0.27 0.00 0.00 0.00 20.00 20.00
19.24 24.58 33.32 64.21 63.01 64.56 46.46 48.94
Total Assets 43.05 45.21 53.74 88.48 84.40 82.55 82.94 84.00

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
8.95 4.62 4.35 7.83 10.97 5.52 2.36 1.67
1.00 -0.01 -3.22 -35.74 -0.29 -10.60 -0.21 0.06
-5.81 -1.56 -1.22 28.72 -10.37 -0.49 -3.10 -1.63
Net Cash Flow 4.14 3.05 -0.10 0.80 0.32 -5.57 -0.95 0.10
Free Cash Flow 9.95 4.61 1.13 1.36 11.02 4.88 1.49 1.19
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 114% 61% 49% 96% 162% 129% 78% 55%

Ratios

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 102.03 92.57 97.25 65.96 90.69 7.85 18.90 31.73
Inventory Days 16.98 12.88 18.17 25.99
Days Payable 116.72 -25.76 213.05 135.84
Cash Conversion Cycle 2.29 131.22 -97.64 -43.89 90.69 7.85 18.90 31.73
Working Capital Days 256.25 291.69 -189.31 54.52 43.46 243.18 -13.39 33.58
ROCE % 10.13% 13.99% 10.09% 8.17% 7.95% 6.17% 5.99%

Insights

In beta
Mar 2015 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Pathology Revenue Share
%

Log in to view insights

Please log in to see hidden values.

Login
Radiology Revenue Share
%
Number of Permanent Employees
count
Number of Diagnostic Centres
count
Number of Diagnostic Services Offered
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
71.22% 71.22% 71.22% 62.79% 57.04% 57.04% 57.04% 57.04% 57.04% 57.04% 57.04% 57.04%
28.79% 28.78% 28.78% 37.21% 42.96% 42.96% 42.96% 42.96% 42.96% 42.96% 42.96% 42.96%
No. of Shareholders 2,7912,5162,4402,7772,8442,7902,5812,4892,4372,3622,3592,323

Documents

Announcements

Annual reports

DRHP

Credit ratings